Captrust Financial Advisors Bausch Health Companies Inc. Transaction History

Captrust Financial Advisors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 23, 2022	SELL	$7.06 - $23.63 $1,059 - $3,544	-150 Reduced 2.79%	5,222 $44,000
Q2 2022 Aug 16, 2022	BUY	$7.06 - $23.63 $8,909 - $29,821	1,262 Added 30.71%	5,372 $45,000
Q1 2022 May 16, 2022	BUY	$21.6 - $27.79 $3,780 - $4,863	175 Added 4.45%	4,110 $94,000
Q4 2021 Feb 14, 2022	BUY	$23.0 - $29.01 $23,805 - $30,025	1,035 Added 35.69%	3,935 $109,000
Q3 2021 Nov 16, 2021	BUY	$25.04 - $30.06 $5,008 - $6,012	200 Added 7.41%	2,900 $81,000
Q1 2021 May 17, 2021	SELL	$21.37 - $34.38 $17,843 - $28,707	-835 Reduced 23.62%	2,700 $86,000
Q2 2020 Aug 14, 2020	BUY	$13.31 - $20.51 $47,050 - $72,502	3,535 New	3,535 $65,000
Q4 2019 Feb 14, 2020	SELL	$18.89 - $31.89 $53,553 - $90,408	-2,835 Closed	0 $0
Q2 2019 Aug 13, 2019	BUY	$20.52 - $26.45 $17,134 - $22,085	835 Added 41.75%	2,835 $71,000
Q3 2018 Nov 15, 2018	BUY	$20.64 - $25.67 $41,280 - $51,340	2,000 New	2,000 $51,000

255

253M

5.53M

16.5M

Ticker BHC
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 361,728,000
Market Cap $3.07B
Description
Bausch Health Companies Inc., together with its subsidiaries, develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products primarily in the therapeutic areas of eye health, gastroenterology, and dermatology. The company operates through five segments: Bausch + Lomb, Salix, International Rx, O...

Get notified when there are updates to the investment portfolio of Captrust Financial Advisors, based on Form 13F filings with the SEC.

Stay updated on Captrust Financial Advisors with notifications on news.